Vital Therapies reported $-19155000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Epizyme EPZM:US $ -62.82M 6.9M
Insmed INSM:US $ -91545000 6.9M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Omeros OMER:US $ -17936000 5.72M
Quidel QDEL:US $ 294.63M 255.81M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
United Therapeutics UTHR:US $ 242.3M 7.7M
Xoma XOMA:US $ -3343000 281K